+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Monocyte Activation Tests - Global Market Trajectory & Analytics

  • ID: 5140637
  • Report
  • April 2021
  • Region: Global
  • 173 pages
  • Global Industry Analysts, Inc
1 of 2
Global Monocyte Activation Tests Market to Reach $19.9 Million by 2027

Amid the COVID-19 crisis, the global market for Monocyte Activation Tests estimated at US$8.2 Million in the year 2020, is projected to reach a revised size of US$19.9 Million by 2027, growing at a CAGR of 13.4% over the period 2020-2027. Monocyte Activation Test Kits, one of the segments analyzed in the report, is projected to record 14.7% CAGR and reach US$10.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 12.1% CAGR for the next 7-year period.



The U.S. Market is Estimated at $2.4 Million, While China is Forecast to Grow at 12.9% CAGR

The Monocyte Activation Tests market in the U.S. is estimated at US$2.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.5 Million by the year 2027 trailing a CAGR of 12.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12% and 11.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Select Competitors (Total 41 Featured):
  • Becton, Dickinson & Company
  • Charles River Laboratories International, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Microcoat Biotechnologie GmbH
  • Sanquin
  • Solvias AG
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
2 of 2
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Monocyte Activation Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Monocyte Activation Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Monocyte Activation Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Blood Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Blood Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Cell Line Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Cell Line Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 19: World Current & Future Analysis for Other End-Use Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 20: World 7-Year Perspective for Other End-Use Industries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 21: USA Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 22: USA 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 23: USA Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 24: USA 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 25: USA Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 26: USA 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • CANADA
  • Table 27: Canada Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 28: Canada 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 29: Canada Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 30: Canada 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 31: Canada Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 32: Canada 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • JAPAN
  • Table 33: Japan Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 34: Japan 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 35: Japan Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 36: Japan 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 37: Japan Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 38: Japan 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • CHINA
  • Table 39: China Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 40: China 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 41: China Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 42: China 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 43: China Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 44: China 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • EUROPE
  • Table 45: Europe Current & Future Analysis for Monocyte Activation Tests by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 46: Europe 7-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 47: Europe Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 48: Europe 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 49: Europe Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 50: Europe 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 51: Europe Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 52: Europe 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • FRANCE
  • Table 53: France Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 54: France 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 55: France Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 56: France 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 57: France Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 58: France 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • GERMANY
  • Table 59: Germany Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 60: Germany 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 61: Germany Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 62: Germany 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 63: Germany Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 64: Germany 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • ITALY
  • Table 65: Italy Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 66: Italy 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 67: Italy Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 68: Italy 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 69: Italy Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 70: Italy 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 71: UK Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 72: UK 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 73: UK Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 74: UK 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 75: UK Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 76: UK 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 77: Rest of Europe Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 78: Rest of Europe 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 79: Rest of Europe Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 80: Rest of Europe 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 81: Rest of Europe Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 82: Rest of Europe 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 83: Asia-Pacific Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 84: Asia-Pacific 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 85: Asia-Pacific Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 86: Asia-Pacific 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 87: Asia-Pacific Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 88: Asia-Pacific 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
  • REST OF WORLD
  • Table 89: Rest of World Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 90: Rest of World 7-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2020 & 2027
  • Table 91: Rest of World Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 92: Rest of World 7-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2020 & 2027
  • Table 93: Rest of World Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 94: Rest of World 7-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 41
Note: Product cover images may vary from those shown
Adroll
adroll